XML 22 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statement Of Changes In Stockholders' Equity (Deficit) - USD ($)
Total
Revision of Prior Period, Error Correction, Adjustment
Notes Payable
Private Placement
Series C Preferred Subscription Agreements
Global Technology Management Resources, Inc
Warrant
Pre-Funded Warrants
Common Stock
Common Stock
Notes Payable
Common Stock
Private Placement
Common Stock
Series C Preferred Subscription Agreements
Common Stock
Global Technology Management Resources, Inc
Common Stock
Warrant
Common Stock
Pre-Funded Warrants
Additional Paid-In Capital
Additional Paid-In Capital
Revision of Prior Period, Error Correction, Adjustment
Additional Paid-In Capital
Notes Payable
Additional Paid-In Capital
Private Placement
Additional Paid-In Capital
Series C Preferred Subscription Agreements
Additional Paid-In Capital
Global Technology Management Resources, Inc
Additional Paid-In Capital
Warrant
Additional Paid-In Capital
Pre-Funded Warrants
Accumulated Deficit
Accumulated Deficit
Revision of Prior Period, Error Correction, Adjustment
Series A Preferred
Preferred Stock
Series B Preferred
Series B Preferred
Preferred Stock
Series B Preferred
Common Stock
Series B Preferred
Additional Paid-In Capital
Series C Preferred
Preferred Stock
Series C Preferred
Preferred Stock
Series C Preferred Subscription Agreements
Series C Preferred
Common Stock
Beginning balance (in shares) at Dec. 31, 2021                 19,960,632                                 5,875,000   3,610,000     620,000    
Beginning balance at Dec. 31, 2021 $ 15,322,117               $ 1,996             $ 26,405,126               $ (11,086,016)   $ 588   $ 361     $ 62    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                                  
Stock-based compensation – options 4,985,233                             4,985,233                                  
Stock-based compensation - warrants             $ 3,496,912                             $ 3,496,912                      
Shares issued in exercise of stock options (in shares)                 15,000                                                
Shares issued in exercise of stock options 12,000               $ 2             11,998                                  
Stock issued during period, shares, new issues (in shares)                 132,500     15,000                                       150,000  
Stock issued during period, value, new issues 533,750       $ 150,000       $ 13     $ 2       533,737       $ 149,983                       $ 15  
Stock-based compensation - shares issued for services and restricted stock (in shares)                 75,000                                                
Stock-based compensation - shares issued for services and Restricted stock 379,499               $ 8             379,491                                  
Shares issued for uplisting (in shares)                 1,351,231                                                
Shares issued for uplisting, net of offering costs of approximately $$700,000 2,000,756               $ 135             2,000,621                                  
Shares issued for cash including fair value adjustment (in shares)                 1,250,000                                                
Shares issued for cash including fair value adjustment 500,000               $ 125             499,875                                  
Debt discount recognized for obligation to issue common stock (100,000)                             (100,000)                                  
Fair value adjustment on common stock for Crom 93,000                             93,000                                  
Deferred issuance costs (in shares)                 125,000                                                
Deferred issuance costs 59,300               $ 12             59,288                                  
Common shares issued in conversion (in shares)                   100,000                                   (3,610,000) 18,050,000        
Common shares issued in conversion     $ 160,000             $ 10               $ 159,990                 $ 0 $ (361) $ 1,805 $ (1,444)      
Extinguishment of debt discount related to debt issuance 0                                                                
Net loss (15,008,554)                                             (15,008,554)                  
Ending balance (in shares) at Dec. 31, 2022                 41,699,363                                 5,875,000   0     770,000    
Ending balance at Dec. 31, 2022 17,531,916               $ 4,170             43,621,651               (26,094,570)   $ 588   $ 0     $ 77    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                                  
Stock-based compensation – options 5,923,200                             5,923,200                                  
Stock-based compensation - warrants             1,076,969                             1,076,969                      
Shares issued in acquisition (in shares)                         4,866,570                                        
Shares issued in acquisition           $ 5,304,562             $ 487               $ 5,304,075                        
Stock issued during period, shares, new issues (in shares)                     63,000                                       150,000   300,000
Stock issued during period, value, new issues       $ 126,000             $ 6               $ 125,994                            
Stock-based compensation - shares issued for services and restricted stock (in shares)                 462,244                                                
Stock-based compensation - shares issued for services and Restricted stock 423,659               $ 45             423,614                                  
Deferred issuance costs 0                                                                
Common shares issued in conversion (in shares)                 556,250                                                
Common shares issued in conversion 590,000               $ 56             589,944                                  
Loss on induced conversion 300,000                             300,000                                  
Extinguishment of debt discount related to derivative liability (171,128)                             (171,128)                                  
Extinguishment of debt discount related to debt issuance (8,034)                             (8,034)                                  
Extinguishment of derivative liability 33,375                             33,375                                  
Stock issued as commitment shares in Crom transaction (in shares)                 25,000                                                
Shares issued as commitment shares in Crom Transaction 11,000               $ 3             10,997                                  
Balance sheet reclassification adjustment [1]   $ (274,500)                             $ (304,500)               $ 30,000                
Net loss (17,918,330)                                             (17,918,330)                  
Ending balance (in shares) at Dec. 31, 2023                 47,672,427                                 5,875,000   0     770,000    
Ending balance at Dec. 31, 2023 12,948,689               $ 4,767             56,926,157               (43,982,900)   $ 588   $ 0     $ 77    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                                  
Stock-based compensation – options 5,280,217                             5,280,217                                  
Stock issued during period, shares, new issues (in shares)                 5,357,487                                               770,000
Stock issued during period, value, new issues 755,767               $ 536             755,231                                  
Sale of common stock, net of filing fees (in shares)                 13,828,701                                                
Sale of common stock, net of filing fees 6,467,355               $ 1,382             6,465,973                                  
Pre-funded warrants issued to institutional investor (in shares)                           7,137,501 3,080,013                                    
Pre-funded warrants issued to institutional investor             $ 4,300,597 $ 528,985           $ 714 $ 308             $ 4,299,883 $ 528,677                    
Deferred issuance costs 0                                                                
Extinguishment of debt discount related to debt issuance 0                                                                
Net loss (10,099,584)                                             (10,099,584)                  
Ending balance (in shares) at Dec. 31, 2024                 77,076,129                                 5,875,000   0     770,000    
Ending balance at Dec. 31, 2024 $ 20,182,026               $ 7,707             $ 74,256,138               $ (54,082,484)   $ 588   $ 0     $ 77    
[1]
(a) In the second quarter of 2023, the Company made an immaterial balance sheet reclassification to reduce additional paid in capital by $304,500 and to increase the obligation to issue common shares account and the accumulated deficit account by $274,500 and $30,000, respectively. These immaterial amounts are also reflected in the Company's Consolidated Balance Sheets, Consolidated Statements of Cash Flows, and the Consolidated Statement of Changes in Stockholders' Equity.